EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combined Maxacalcitol/Betamethasone Butyrate Propionate Ointment Possesses Long‐Term Sustained Effects of Inducing Regulatory T Cells and Downregulating the Th17 Response, Even After Discontinuation of Its Application in Imiquimod‐Induced Psoriasiform Dermatitis

Teruo Shimizu, Masahiro Kamata iD, Hideya Uratsuji, Yoshiki Okada, Ayu Watanabe, Azusa Hiura, Yayoi Tomura, Yayoi Tada iD

The Journal of Dermatology · 2026

DOI: 10.1111/1346-8138.70031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Dermatology, 2026. Verfasst von Teruo Shimizu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Calcitriol, Th17 Cells, Psoriasis. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Maruho Co., Ltd., Maruho.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We often experience sustained improvement, even after discontinuation of treatment in psoriasis lesions treated with topical vitamin D 3 (VD 3 ) or the combination of topical corticosteroids and VD 3 . However, the underlying mechanisms of these sustained effects remain unclear. We explored mechanisms for the sustained effects of maxacalcitol (MCT) and combined MCT/betamethasone butyrate propionate (BBP) ointments using a murine psoriasiform dermatitis model induced by imiquimod (IMQ). IMQ was applied once daily to the shaved backs of mice for 6 days to induce psoriasiform dermatitis. MCT, BBP, combined MCT/BBP ointment, or their vehicles were treated for 3 days prior to IMQ application. IMQ was reapplied after 1, 2, or 3 weeks from the first IMQ application to investigate the sustained effects of their ointments. In the first application of IMQ, the administration of MCT, BBP, or MCT/BBP ointment improved clinical and pathological manifestations and reduced Th17‐related cytokines. Treatment with MCT or MCT/BBP showed an increase in IL‐10 mRNA expression and a higher count of Foxp3 + cells within the skin, but not in those with BBP. The induction of IL‐10 by MCT and MCT/BBP persisted until reapplication of IMQ 2 weeks later, although their effects diminished 3 weeks later. The reduction in Th17‐related cytokines was maintained up to 3 weeks later in MCT/BBP, whereas it was not observed 2 weeks later in MCT. In conclusion, MCT and MCT/BBP showed long‐term effects by induction of regulatory T cells and IL‐10. Additionally, MCT/BBP downregulated Th17‐related cytokines, which could contribute to the sustained improvement after discontinuation observed in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryCalcitriolTh17 CellsPsoriasisBetamethasoneAnimalsImiquimodOintmentsMiceDisease Models, AnimalSkinDown-RegulationFemaleDrug Therapy, CombinationDrug CombinationsMice, Inbred BALB CHumansAdministration, Cutaneous

Stichwörter der Autor:innen

betamethasone butyrate propionateinterleukin‐10interleukin‐17maxacalcitolpsoriasisregulatory T cells

Substanzen

ImiquimodCalcitriolOintmentsmaxacalcitolBetamethasoneDrug Combinations

Autor:innen und Institutionen

  • Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
  • Maruho Co., Ltd., Osaka, Japan.

ORCID-Profile: Masahiro Kamata, Yayoi Tada

Förderung

  • Maruho Co., Ltd.
  • Maruho

Zitieren

APA

Shimizu, T., Kamata, M., Uratsuji, H., Okada, Y., Watanabe, A., Hiura, A., Tomura, Y., & Tada, Y. (2026). Combined Maxacalcitol/Betamethasone Butyrate Propionate Ointment Possesses Long‐Term Sustained Effects of Inducing Regulatory T Cells and Downregulating the Th17 Response, Even After Discontinuation of Its Application in Imiquimod‐Induced Psoriasiform Dermatitis. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.70031

Vancouver

Shimizu T, Kamata M, Uratsuji H, Okada Y, Watanabe A, Hiura A, et al. Combined Maxacalcitol/Betamethasone Butyrate Propionate Ointment Possesses Long‐Term Sustained Effects of Inducing Regulatory T Cells and Downregulating the Th17 Response, Even After Discontinuation of Its Application in Imiquimod‐Induced Psoriasiform Dermatitis. The Journal of Dermatology. 2026. doi:10.1111/1346-8138.70031

BibTeX
@article{Shimizu2026,
  author = {Shimizu, Teruo and Kamata, Masahiro and Uratsuji, Hideya and Okada, Yoshiki and Watanabe, Ayu and Hiura, Azusa and Tomura, Yayoi and Tada, Yayoi},
  title = {Combined Maxacalcitol/Betamethasone Butyrate Propionate Ointment Possesses Long‐Term Sustained Effects of Inducing Regulatory T Cells and Downregulating the Th17 Response, Even After Discontinuation of Its Application in Imiquimod‐Induced Psoriasiform Dermatitis},
  journal = {The Journal of Dermatology},
  year = {2026},
  doi = {10.1111/1346-8138.70031}
}
Kostenlos starten →